Speaker

Adi Mor

Biography :

Chief executive Officer, Chief Scientific Officer and Co-founder at Chemomab Therapeutics Adi Mor founded Chemomab at 2011 and has been leading Chemomab as its CEO and CSO from early discovery stage and into Phase 2/3 clinical trials. She has extensive knowledge and experience in immunology focusing on autoimmune and inflammatory-fibrotic diseases and broad experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and fibrotic diseases. Dr. Mor is a senior executive with a track record of strong cross functional leadership with deep understanding of drug development, business development, corporate strategy and clinical operations.